Both are GLP-1 receptor agonists that help with weight loss by regulating insulin secretion, reducing appetite, and slowing down gastric emptying
One analysis of several hundred GLP-1 studies presented compelling evidence that they improve cognitive disorders, such as Alzheimers, substance-use disorders, such as alcohol, cocaine, and cannabis addiction, and mood and anxiety disorders, such as depression and bipolar disorder
For patients who anticipate stopping treatment, lifestyle changes during the medicated weight-loss period (diet quality improvements, regular exercise habits, sleep hygiene) may help preserve some of the BP benefit even if weight rebounds partially
Regular use of Spa Ruca Glutathione Face Wash helps reduce dark spots and improves overall complexion
Serge Jabbour from Thomas Jefferson University in Philadelphia, Pennsylvania, and colleagues aimed to describe the clinical course in terms of body weight, glycemic outcomes, and adverse events during the first 12 weeks following a switch from GLP-1 receptor agonists directly to tirzepatide 5 mg in a prospective study
Sachs, S